Thoratec issues urgent medical device correction letter for HeartMate II device

Thoratec voluntarily issued an urgent medical device correction letter on Sept. 16 alerting hospitals to monitor the expiration date of the backup battery contained in the HeartMate II left ventricular assist system device.

The company noted that the backup battery has a 36-month expiration date. At that end of the 36 months, an advisory alarm is activated, although Thoratec said the alarm does not affect the device’s functioning.

Several hospitals notified Thoratec on Sept. 1 that patients had heard the advisory alarm because their backup batteries had expired. Three patients were unable to connect their pump to their backup system controller. Two of the patients died and one sustained a serious injury, according to Thoratec.

In its correction letter, Thoratec said it was “working with hospital staff to identify patients that may be close to reaching the 36-month expiration date of their System Controller backup battery in order to facilitate priority replacement and to ensure routine monitoring of backup battery lifetime during clinic visits, as specified in the product Instructions for Use.”

The HeartMate II is intended for cardiac transplant candidates with advanced heart failure who are at the risk of imminent death from left ventricular failure.

In July, St. Jude Medical agreed to acquire Thoratec for approximately $3.4 billion pending shareholder approval, regulatory approval and other customary closing conditions.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.